ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,088Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 783

$839K Total Retail Price of All Prescriptions

Rank: 82 out of 783

437 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

30% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 16,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 977 837 1 4
HYDROCODONE-ACETAMINOPHEN 937 776 S3 2 2
OMEPRAZOLE 807 701 3 6
SIMVASTATIN 791 736 4 3
LEVOTHYROXINE SODIUM 718 655 5 1
FUROSEMIDE 577 524 6 7
METOPROLOL TARTRATE 451 413 7 9
POTASSIUM CHLORIDE 381 327 8 16
METFORMIN HCL 381 310 8 8
AMLODIPINE BESYLATE 318 303 10 5
ALLOPURINOL 318 307 10 31
PRAVASTATIN SODIUM 310 271 12 14
WARFARIN SODIUM 276 244 13 10
CITALOPRAM HBR 275 236 14 19
ATORVASTATIN CALCIUM 265 246 15 11
ATENOLOL 262 239 16 17
TRIAMTERENE-HCTZ 248 195 17 42
GLIMEPIRIDE 240 225 18 34
RANITIDINE HCL 231 203 19 44
DONEPEZIL HCL 227 227 20 24
BISOPROLOL FUMARATE 209 156 21 202
SPIRONOLACTONE 206 169 22 57
NAMENDA 199 199 23 32
GABAPENTIN 194 165 24 15
LOSARTAN POTASSIUM 194 180 24 18
CEPHALEXIN 194 162 24 70
ISOSORBIDE MONONITRATE ER 190 190 27 40
CLOPIDOGREL 184 176 28 29
METOPROLOL SUCCINATE 181 158 29 13
MIRTAZAPINE 178 178 30 52
LOVASTATIN 171 139 31 58
TERAZOSIN HCL 170 168 32 130
FAMOTIDINE 168 158 33 55
CARVEDILOL 165 143 34 21
GLIPIZIDE 152 127 35 71
TRAMADOL HCL 143 110 36 20
PLAVIX 121 116 37 51
AZITHROMYCIN 115 94 38 41
ZOLPIDEM TARTRATE 113 87 39 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 104 40 33
POLYETHYLENE GLYCOL 3350 104 71 41 43
TAMSULOSIN HCL 98 93 42 26
HYDRALAZINE HCL 97 97 43 78
ALENDRONATE SODIUM 96 96 44 25
SERTRALINE HCL 96 94 44 22
CRESTOR 96 55 44 27
DIOVAN 93 93 47 49
BISOPROLOL-HYDROCHLOROTHIAZIDE 93 89 47 154
FLUTICASONE PROPIONATE 88 58 49 46
GLYBURIDE 87 85 R 50 111
MELOXICAM 84 69 51 37
PANTOPRAZOLE SODIUM 82 71 52 30
TRAZODONE HCL 81 66 53 39
KLOR-CON 10 79 68 54 102
CYMBALTA 78 68 55 35
PAROXETINE HCL 77 55 56 69
DIGOXIN 76 76 57 61
ADVAIR DISKUS 76 70 57 50
HUMALOG 75 61 59 101
DOXYCYCLINE HYCLATE 74 68 60 112
CYCLOBENZAPRINE HCL 73 17 R 61 63
RISPERIDONE 72 58 62 67
LANTUS 72 61 62 38
CALCITONIN-SALMON 71 71 64 388
FENTANYL 68 64 S2 65 65
CIPROFLOXACIN HCL 64 62 66 62
OXYBUTYNIN CHLORIDE ER 64 59 66 117
INSULIN SYRINGE 61 59 68 82
NEXIUM 61 33 68 28
ACARBOSE 61 49 68 347
DIVALPROEX SODIUM 61 51 68 72
NOVOLOG 60 53 72 81
OXYBUTYNIN CHLORIDE 59 59 73 96
METHADONE HCL 59 59 S2 73 193
NITROFURANTOIN MONO-MACRO 58 55 75 174
LOSARTAN-HYDROCHLOROTHIAZIDE 58 46 75 53
VENTOLIN HFA 57 41 77 159
HYDROCHLOROTHIAZIDE 56 37 78 12
DILTIAZEM 24HR CD 54 54 79 118
DILTIAZEM 24HR ER 54 43 79 122
KLOR-CON M10 52 45 81 137
LIPITOR 51 42 82 114
OXYCODONE HCL-ACETAMINOPHEN 51 46 S2 82 86
FELODIPINE ER 50 38 84 221
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.